MPM Capital Closes Biotech-Focused Fund With $400M
Life sciences-focused venture capital firm MPM Capital said on Thursday that it has closed its latest fund with $400 million in contributions that will be used to fund early-stage biotech innovation....To view the full article, register now.
Already a subscriber? Click here to view full article